Proposed Changes to 340B Program Would Hurt Nonprofit Hospital Margins, Moody’s Says
Hospitals will continue to pay more for inpatient drugs, though Moody’s predicts the pace will moderate due to pharmaceutical scrutiny.
Proposed Changes to 340B Program Would Hurt Nonprofit Hospital Margins, Moody’s Says
Hospitals will continue to pay more for inpatient drugs, though Moody’s predicts the pace will moderate due to pharmaceutical scrutiny.